Year |
Citation |
Score |
2015 |
Boquoi A, Arora S, Chen T, Litwin S, Koh J, Enders GH. Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a. Aging Cell. 14: 139-47. PMID 25481981 DOI: 10.1111/Acel.12279 |
0.465 |
|
2012 |
Enders GH. Mammalian interphase cdks: dispensable master regulators of the cell cycle. Genes & Cancer. 3: 614-8. PMID 23634250 DOI: 10.1177/1947601913479799 |
0.441 |
|
2012 |
von Holzen U, Enders GH. A surprise cell of origin for Barrett's esophagus. Cancer Biology & Therapy. 13: 588-91. PMID 22549156 DOI: 10.4161/Cbt.20088 |
0.381 |
|
2011 |
Boquoi A, Chen T, Litwin S, Enders GH. Abstract 2975: Widespread cell cycle inhibition and features of premature aging in mice with conditional expression of p16Ink4a Cancer Research. 71: 2975-2975. DOI: 10.1158/1538-7445.Am2011-2975 |
0.549 |
|
2010 |
Kennedy AL, McBryan T, Enders GH, Johnson FB, Zhang R, Adams PD. Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Division. 5: 16. PMID 20569479 DOI: 10.1186/1747-1028-5-16 |
0.38 |
|
2010 |
Enders GH. Gauchos and ochos: a Wee1-Cdk tango regulating mitotic entry. Cell Division. 5: 12. PMID 20465818 DOI: 10.1186/1747-1028-5-12 |
0.313 |
|
2010 |
von Holzen U, Chen T, Boquoi A, Richter JE, Falk GW, Klein-Szanto AJ, Cooper H, Litwin S, Weinberg DS, Enders GH. Evidence for DNA damage checkpoint activation in barrett esophagus. Translational Oncology. 3: 33-42. PMID 20165693 DOI: 10.1593/Tlo.09187 |
0.478 |
|
2010 |
Li C, Andrake M, Dunbrack R, Enders GH. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Molecular and Cellular Biology. 30: 116-30. PMID 19858290 DOI: 10.1128/Mcb.01876-08 |
0.358 |
|
2009 |
Boquoi A, Chen T, Enders GH. Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032. Cancer Prevention Research (Philadelphia, Pa.). 2: 800-6. PMID 19723896 DOI: 10.1158/1940-6207.Capr-09-0053 |
0.496 |
|
2009 |
Payá A, Alenda C, Pérez-Carbonell L, Rojas E, Soto JL, Guillén C, Castillejo A, Barberá VM, Carrato A, Castells A, Llor X, Andreu M, Koh J, Enders GH, Benlloch S, et al. Utility of p16 immunohistochemistry for the identification of Lynch syndrome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3156-62. PMID 19383812 DOI: 10.1158/1078-0432.CCR-08-3116 |
0.378 |
|
2009 |
Boquoi A, Jover R, Chen T, Pennings M, Enders GH. Transgenic expression of VEGF in intestinal epithelium drives mesenchymal cell interactions and epithelial neoplasia. Gastroenterology. 136: 596-606.e4. PMID 19056388 DOI: 10.1053/J.Gastro.2008.10.028 |
0.417 |
|
2008 |
Adams PD, Enders GH. Wnt-signaling and senescence: A tug of war in early neoplasia? Cancer Biology and Therapy. 7: 1706-1711. PMID 18836285 DOI: 10.4161/Cbt.7.11.6943 |
0.436 |
|
2008 |
Enders GH. Expanded roles for Chk1 in genome maintenance. The Journal of Biological Chemistry. 283: 17749-52. PMID 18424430 DOI: 10.1074/Jbc.R800021200 |
0.394 |
|
2006 |
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics. 38: 1060-5. PMID 16878133 DOI: 10.1038/Ng1855 |
0.407 |
|
2006 |
Furth EE, Gustafson KS, Dai CY, Gibson SL, Menard-Katcher P, Chen T, Koh J, Enders GH. Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitis. Neoplasia (New York, N.Y.). 8: 429-36. PMID 16820088 DOI: 10.1593/Neo.06169 |
0.76 |
|
2006 |
Mitra J, Enders GH, Azizkhan-Clifford J, Lengel KL. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes. Cell Cycle (Georgetown, Tex.). 5: 661-6. PMID 16582612 DOI: 10.4161/Cc.5.6.2604 |
0.396 |
|
2006 |
Enders GH, Maude SL. Traffic safety for the cell: influence of cyclin-dependent kinase activity on genomic stability. Gene. 371: 1-6. PMID 16458456 DOI: 10.1016/J.Gene.2005.11.017 |
0.601 |
|
2005 |
Gibson SL, Boquoi A, Chen T, Sharpless NE, Brensinger C, Enders GH. p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors. Cancer Biology & Therapy. 4: 1389-94. PMID 16322687 DOI: 10.4161/Cbt.4.12.2303 |
0.582 |
|
2005 |
Maude SL, Enders GH. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. Cancer Research. 65: 780-6. PMID 15705874 |
0.588 |
|
2004 |
Mitra J, Enders GH. Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene. 23: 3361-7. PMID 14767478 DOI: 10.1038/Sj.Onc.1207446 |
0.411 |
|
2003 |
Kalabis J, Patterson MJ, Enders GH, Marian B, Iozzo RV, Rogler G, Gimotty PA, Herlyn M. Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1115-7. PMID 12692084 DOI: 10.1096/Fj.02-0852Fje |
0.395 |
|
2003 |
Gibson SL, Dai CY, Lee HW, DePinho RA, Gee MS, Lee WM, Furth EE, Brensinger C, Enders GH. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Research. 63: 742-6. PMID 12591718 |
0.748 |
|
2002 |
Enders GH. Cyclins in breast cancer: too much of a good thing. Breast Cancer Research : Bcr. 4: 145-7. PMID 12100739 DOI: 10.1186/Bcr439 |
0.314 |
|
2001 |
Hu B, Mitra J, van den Heuvel S, Enders GH. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Molecular and Cellular Biology. 21: 2755-66. PMID 11283255 DOI: 10.1128/Mcb.21.8.2755-2766.2001 |
0.441 |
|
2001 |
Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA. A family of tissue-specific resistin-like molecules. Proceedings of the National Academy of Sciences of the United States of America. 98: 502-6. PMID 11209052 DOI: 10.1073/Pnas.98.2.502 |
0.724 |
|
2001 |
Dai CY, Steven L. G, Gee MS, Lee WM, Lee H, Depinho RA, Enders GH. Suppression of mouse colon tumor angiogenesis by the INK4a/ARF locus Gastroenterology. 120: A296. DOI: 10.1016/S0016-5085(08)81469-2 |
0.74 |
|
2000 |
Dai CY, Furth EE, Mick R, Koh J, Takayama T, Niitsu Y, Enders GH. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology. 119: 929-42. PMID 11040180 DOI: 10.1053/Gast.2000.17952 |
0.782 |
|
2000 |
Dai CY, Enders GH. p16 INK4a can initiate an autonomous senescence program. Oncogene. 19: 1613-22. PMID 10763818 DOI: 10.1038/Sj.Onc.1203438 |
0.74 |
|
1999 |
Prabhu NS, Somasundaram K, Tian H, Enders GH, Satyamoorthy K, Herlyn M, El-Deiry WS. The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity International Journal of Oncology. 15: 209-216. PMID 10402229 DOI: 10.3892/Ijo.15.2.209 |
0.423 |
|
1999 |
Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Molecular and Cellular Biology. 19: 3916-28. PMID 10207115 DOI: 10.1128/Mcb.19.5.3916 |
0.753 |
|
Show low-probability matches. |